Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge (vol 72, pg 2035, 2017)

Elliot, Emilie R, Amara, Alieu ORCID: 0000-0002-1137-2948, Pagani, Nicole, Else, Laura, Moyle, Graeme, Schoolmeesters, Alex, Higgs, Chris, Khoo, Saye ORCID: 0000-0002-2769-0967 and Boffito, Marta (2017) Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge (vol 72, pg 2035, 2017). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72 (7). p. 2143.

Text
Elliot E_Once daily atazanavircobicistat and darunavircobicistat exposure over 72 hours post dose in plasma, urine and saliva, contribution to drug pharmacokinetic knowledge V3.0_copy.pdf - Author Accepted Manuscript
Download (530kB) | Preview

Official URL: http://dx.doi.org/10.1093/jac/dkx145

Abstract

In Table 2 of the original published version of this article the entry in the 30 h column for 'Darunavir (ng/mL), GM (range)' was incorrectly given as '382 (97-257)'. The correct entry is '382 (97-2057)'. This error has nowbeen corrected.

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	21 Feb 2020 14:01
Last Modified:	19 Jan 2023 07:03
DOI:	10.1093/jac/dkx145
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3007732